1985PubMedRequires access

[Recurrence of chronic duodenal ulcer following initial therapy with pirenzepine or cimetidine].

Enno Hentschel, K Schütze, W Dufek

Open publisher page 0 citations

Abstract

Recurrence rates of chronic duodenal ulcer after initial therapy with pirenzepine or cimetidine were investigated in a prospective, randomized trial with a total of 80 patients. After 12 weeks of therapy with pirenzepine (50 mg b.i.d) or cimetidine (200 mg t.i.d. + 400 mg nocte) 68,7% and 88,5% respectively were healed (chi 2 = 3,97; p less than 0,05). These patients showed recurrences in 73,6% after pirenzepine and in 84,6% after cimetidine during a six months observation period. This difference is not statistically significant, nor was life table analysis capable to show any difference in the relapse pattern between the two groups.

About this research paper

What this paper is about

Recurrence rates of chronic duodenal ulcer after initial therapy with pirenzepine or cimetidine were investigated in a prospective, randomized trial with a total of 80 patients. After 12 weeks of therapy with pirenzepine (50 mg b.i.d) or cimetidine (200 mg t.i.d. + 400 mg nocte) 68,7% and 88,5% respectively were healed (chi 2 = 3,97; p less than 0,05). These patients showed recurrences in 73,6% after pirenzepine and in 84,6% after cimetidine during a six months observation period. This difference is not statistically significant, nor was life table analysis capable to show any difference in the relapse pattern between the two groups.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Recurrence rates of chronic duodenal ulcer after initial therapy with pirenzepine or cimetidine were investigated in a prospective, randomized trial with a total of 80 patients. After 12 weeks of therapy with pirenzepine (50 mg b.i.d) or cimetidine (200 mg t.i.d. + 400 mg nocte) 68,7% and 88,5% respectively were healed (chi 2 = 3,97; p less than 0,05). These patients showed recurrences in 73,6% after pirenzepine and in 84,6% after cimetidine during a six months observation period. This difference is not statistically significant, nor was life table analysis capable to show any difference in the relapse pattern between the two groups.

Key concepts: Pirenzepine, Cimetidine, Medicine, Duodenal ulcer, Gastroenterology, Internal medicine, Significant difference, Randomized controlled trial

Related papers

Back to paper searchBrowse research topicsOriginal source
[Recurrence of chronic duodenal ulcer following initial therapy with pirenzepine or cimetidine]. — Research Paper | ScholarLens